Carl Zeiss Meditec AG (fra:AFXA) Share Price

Company Profile

Business description
Carl Zeiss Meditec is one of the largest visioncare technology companies in the world. Its ophthalmology segment, which made up about 75% of sales in 2025, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, intraocular lenses, and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. The microsurgery segment is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% share, Zeiss is the clear leader in this market.
Contact
Goschwitzer Strasse 51-52
JenaTH07745
DEU
T: +49 3641220115
https://www.zeiss.com
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
30 September 2027
Employees
5,798

Recommended

Fear outweighs fundamentals as ASX share reaffirms outlook.

Nathan Zaia | 29 October 2026

We now forecast mildly better revenue growth and EPS growth, alongside more intense near-term cash flow pressure.

Eric Compton, CFA | 29 October 2026

We believe that investors are underappreciating the breadth and depth of Alphabet’s AI monetization and the rapid upcoming growth in Google Cloud.

Malik Ahmed Khan, CFA | 29 October 2026

Index	Last price	Change	% Change
All Ordinaries	9,025.40	12.80	0.14%
CAC 40	7,970.57	0.57	0.01%
DAX 40	25,962.51	77.17	-0.30%
Dow JONES (US)	52,342.56	132.54	-0.25%
FTSE 100	10,752.91	30.84	0.29%
HKSE	23,294.42	335.77	1.46%
NASDAQ	26,184.72	365.13	-1.38%
Nikkei 225	63,290.11	1,369.36	-2.12%
NZX 50 Index	13,797.00	86.83	0.63%
S&P 500	7,720.39	23.59	-0.30%
S&P/ASX 200	8,908.10	16.30	0.18%
SSE Composite Index	3,599.02	52.42	-1.44%